WorldPharmaNews
Search ...
Home
Business
Research
Events
Regulatory
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
www.bms.com
.
Bristol-Myers Squibb RSS Channel
Filters
Display #
5
10
15
20
25
30
50
100
All
Filter
List of articles in category Bristol-Myers Squibb
Title
Published Date
Bristol-Myers Squibb announces new collaboration to evaluate combination therapy in colorectal cancer
05 June 2017
Array BioPharma and Bristol-Myers Squibb announce strategic collaboration
30 May 2017
Bristol-Myers Squibb enters into separate agreements with Biogen and Roche to License anti-eTau and anti-myostatin compounds
13 April 2017
The first overall survival data from the Phase 3 CheckMate -067 clinical trial
03 April 2017
Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and the Cancer Research Institute announce collaboration to accelerate immuno-oncology research
28 March 2017
Bristol-Myers Squibb expands focus on precision medicine with investment and planned collaboration with GRAIL
02 March 2017
Bristol-Myers Squibb expands International Immuno-Oncology Network (II-ON)
27 February 2017
Bristol-Myers Squibb appoints three new independent directors
21 February 2017
Bristol-Myers Squibb reports fourth quarter and full year 2016 financial results
26 January 2017
Bristol-Myers Squibb and GeneCentric Diagnostics announce exploratory biomarker research collaboration
10 January 2017
Bristol-Myers Squibb announces immunotherapy clinical collaboration with Janssen
05 January 2017
Bristol-Myers Squibb signs exclusive worldwide license agreement with PsiOxus Therapeutics
20 December 2016
Bristol-Myers Squibb strengthens capabilities with evolution of its U.S. geographic footprint
13 December 2016
Bristol-Myers Squibb reports third quarter results
27 October 2016
Bristol-Myers Squibb Foundation joins White House Cancer Moonshot
18 October 2016
Bristol-Myers Squibb and Nektar Therapeutics announce oncology clinical collaboration to evaluate the combination of Opdivo (nivolumab) and NKTR-214
27 September 2016
Bristol-Myers Squibb awards first "Golden Tickets" for LabCentral to PanTher, Suono Bio
20 September 2016
Bristol-Myers Squibb employees cycle Coast to Coast to raise money and awareness for cancer research
07 September 2016
Bristol-Myers Squibb reports second quarter financial results
29 July 2016
Bristol-Myers Squibb acquires Cormorant Pharmaceuticals
05 July 2016
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
Business & Industry
GSK completes acquisition of Sierra Oncology
Pfizer and BioNTech announce new agreement with U.S. government to provide additional doses of COVID-19 vaccine
Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology
New Novartis extension phase data show nearly 80% of RMS patients treated with Kesimpta® (ofatumumab) had no evidence of disease activity (NEDA-3)
Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against Omicron
Research & Development
Researchers discover new leukemia-killing compounds
Oral antiviral drug effective against respiratory syncytial virus (RSV) identified by researchers
Biomarkers found that could be drug targets against a deadly form of brain cancer
COVID-19 rebound after taking Paxlovid likely due to insufficient drug exposure
Novel drug combo activates natural killer cell immunity to destroy cancer cells
Broadly neutralizing antibodies could provide immunity against SARS-CoV-2 variants
A new technology offers treatment for HIV infection through a single injection
Conferences & Events
New approach to treatment of deadly kidney cancer
SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
SMi's 22nd Annual Pain Therapeutics Conference
SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
SMi's 3rd Annual AI in Drug Discovery Conference
Regulatory Affairs
FDA approves first systemic treatment for alopecia areata
FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
FDA limits use of Janssen COVID-19 vaccine to certain individuals
EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
FDA approves first generic of Symbicort to treat asthma and COPD
You are here:
Home
Bristol-Myers Squibb